Medical and recreational cannabis use is now legal in many parts of the world, but questions remain about its effect on ...

Inversago Pharma, based in Montreal, Canada, is working on safer generations of peripherally-acting cannabinoid receptor-1 (CB1) inverse agonists, based on research carried out by George Kunos ...

Northeastern University has disclosed cannabinoid CB1 receptor allosteric modulators and monoglyceride lipase (MGLL; MAGL) inhibitors reported to be useful for the treatment of pain, inflammation, ...

The study is published in the journal iScience. Cannabis binds to the so-called Cannabinoid receptor 1 (CB1 receptor), one of the most common receptors in our brain. CB1 receptors serve as ...

Heavy lifetime cannabis use is associated with reduced brain activation in key cognitive regions, particularly during working ...

A new study published in JAMA Network Open suggests that frequent marijuana use may negatively impact working memory, ...

Past research has shown that activating CB1 and CB2 receptors with plant-derived compounds can slow down early tumor growth in various cancers, as they act as mediators, triggering different ...

They interact with specific receptors, such as CB1, to influence behaviors related to food and movement. Scientists have long known that manipulating this system can affect weight gain.

Guggenheim Securities SMID Cap Biotech Conference Format: Fireside Chat and one-on-one investor meetings Presentation Date: February 5, 2025 Presentation Time: 2:30 PM Webcast: Click here ...